OBSV News and Press, ObsEva SA From 11/05/20

ObsEva (OBSV): Q3 GAAP EPS of -$0.49 misses by $0.16.Cash and cash equivalents at September 30, 2020 to $50.6M.Press Release For further details see: ObsEva EPS misses by $0.16

Positive Phase 3 PRIMROSE 1 and 2 trial results of linzagolix for the treatment of heavy menstrual bleeding due to uterine fibroids presented in late breaking session of ASRM Virtual Congress Linzagolix regulatory submissions planned for Q4:20/H1:21 in Europe/U.S. ...

DBV Technologies S.A. (DBVT) +80% as EMA approves Viaskin Peanut application.Endurance International Group Holdings (EIGI) +61% on announcing agreement to be acquired by Clearlake Capital Group L.P.AnPac Bio-Medical Science (ANPC) +30% as its Chinese company secu...

Geneva, Switzerland and Boston, MA – 2 November, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced an oral communication and ...

Geneva, Switzerland and Boston, MA – October 22, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the presentation of two posters at...

Geneva, Switzerland and Boston, MA – October 20, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the presentation of a poster at th...

  Geneva, Switzerland and Boston, MA –  September 8, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that CEO Ernest Loumaye ...

DPW Holdings (NYSEMKT: DPW ) +45%  on expecting initial orders for electric vehicle charger product line in Q4. More news on: DPW Holdings, Inc., I-Mab, AnPac Bio-Medical Science Co., Ltd., Stocks on the move, , Read more ...

ObsEva (NASDAQ: OBSV ) is  up 1.8%  in after-hours trading after it announced the pricing of an underwritten equity offering and concurrent private placement transaction. More news on: ObsEva SA, , Healthcare stocks news, Stocks on the move, Read more ...

  GENEVA, Switzerland and BOSTON, MA (September 3, 2020) – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN) (“ObsEva” or the “Company”), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reprod...